List of Tables
Table 1. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Competitive Situation by Manufacturers in 2024
Table 4. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Non Corticosteroid Anti-inflammatory Eyedrops Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Non Corticosteroid Anti-inflammatory Eyedrops, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops, Product Type & Application
Table 12. Global Key Manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non Corticosteroid Anti-inflammatory Eyedrops by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Corticosteroid Anti-inflammatory Eyedrops as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2020-2025) & (K Units)
Table 18. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2020-2025)
Table 19. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2026-2031) & (K Units)
Table 20. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2026-2031)
Table 21. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2020-2025)
Table 23. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2026-2031)
Table 25. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2020-2025) & (K Units)
Table 27. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2026-2031) & (K Units)
Table 28. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2020-2025) & (K Units)
Table 32. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2026-2031) & (K Units)
Table 33. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2020-2025)
Table 51. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Type (2026-2031)
Table 52. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2020-2025)
Table 53. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Type (2026-2031)
Table 54. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2020-2025)
Table 57. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Type (2026-2031)
Table 58. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (USD/Unit) by Type (2020-2025)
Table 59. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (USD/Unit) by Type (2026-2031)
Table 60. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2020-2025)
Table 61. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units) by Application (2026-2031)
Table 62. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2020-2025)
Table 63. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Application (2026-2031)
Table 64. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2020-2025)
Table 67. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Application (2026-2031)
Table 68. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (USD/Unit) by Application (2020-2025)
Table 69. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (USD/Unit) by Application (2026-2031)
Table 70. Novartis AG Company Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. Allergan, Inc. Company Information
Table 76. Allergan, Inc. Description and Business Overview
Table 77. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 79. Allergan, Inc. Recent Developments/Updates
Table 80. Meda Pharmaceuticals Inc Company Information
Table 81. Meda Pharmaceuticals Inc Description and Business Overview
Table 82. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 84. Meda Pharmaceuticals Inc Recent Developments/Updates
Table 85. Bausch & Lomb Inc Company Information
Table 86. Bausch & Lomb Inc Description and Business Overview
Table 87. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 89. Bausch & Lomb Inc Recent Developments/Updates
Table 90. Cigna Company Information
Table 91. Cigna Description and Business Overview
Table 92. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 94. Cigna Recent Developments/Updates
Table 95. Similasan Corporation Company Information
Table 96. Similasan Corporation Description and Business Overview
Table 97. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 99. Similasan Corporation Recent Developments/Updates
Table 100. Visine Company Information
Table 101. Visine Description and Business Overview
Table 102. Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Visine Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 104. Visine Recent Developments/Updates
Table 105. Alcon Company Information
Table 106. Alcon Description and Business Overview
Table 107. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 109. Alcon Recent Developments/Updates
Table 110. Viva Opti-Free Company Information
Table 111. Viva Opti-Free Description and Business Overview
Table 112. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 114. Viva Opti-Free Recent Developments/Updates
Table 115. Bausch & Lomb Company Information
Table 116. Bausch & Lomb Description and Business Overview
Table 117. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 119. Bausch & Lomb Recent Developments/Updates
Table 120. Systane Company Information
Table 121. Systane Description and Business Overview
Table 122. Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Systane Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 124. Systane Recent Developments/Updates
Table 125. Rite Aid Company Information
Table 126. Rite Aid Description and Business Overview
Table 127. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 129. Rite Aid Recent Developments/Updates
Table 130. Walgreens Company Information
Table 131. Walgreens Description and Business Overview
Table 132. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 134. Walgreens Recent Developments/Updates
Table 135. Staples Company Information
Table 136. Staples Description and Business Overview
Table 137. Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Staples Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 139. Staples Recent Developments/Updates
Table 140. Clear eyes Company Information
Table 141. Clear eyes Description and Business Overview
Table 142. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product
Table 144. Clear eyes Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Non Corticosteroid Anti-inflammatory Eyedrops Distributors List
Table 148. Non Corticosteroid Anti-inflammatory Eyedrops Customers List
Table 149. Non Corticosteroid Anti-inflammatory Eyedrops Market Trends
Table 150. Non Corticosteroid Anti-inflammatory Eyedrops Market Drivers
Table 151. Non Corticosteroid Anti-inflammatory Eyedrops Market Challenges
Table 152. Non Corticosteroid Anti-inflammatory Eyedrops Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non Corticosteroid Anti-inflammatory Eyedrops
Figure 2. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Type: 2024 & 2031
Figure 4. Ocufen Product Picture
Figure 5. Mugabe Product Picture
Figure 6. Diclofenac Product Picture
Figure 7. Others Product Picture
Figure 8. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Application: 2024 & 2031
Figure 10. Adult
Figure 11. Children
Figure 12. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size (2020-2031) & (US$ Million)
Figure 14. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (2020-2031) & (K Units)
Figure 15. Global Non Corticosteroid Anti-inflammatory Eyedrops Average Price (USD/Unit) & (2020-2031)
Figure 16. Non Corticosteroid Anti-inflammatory Eyedrops Report Years Considered
Figure 17. Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Manufacturers in 2024
Figure 18. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Non Corticosteroid Anti-inflammatory Eyedrops Players: Market Share by Revenue in Non Corticosteroid Anti-inflammatory Eyedrops in 2024
Figure 20. Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2020-2031)
Figure 23. North America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2020-2031)
Figure 27. Europe Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2020-2031)
Figure 28. Germany Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Region (2020-2031)
Figure 35. China Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2020-2031)
Figure 46. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Non Corticosteroid Anti-inflammatory Eyedrops Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Non Corticosteroid Anti-inflammatory Eyedrops by Type (2020-2031)
Figure 56. Global Revenue Market Share of Non Corticosteroid Anti-inflammatory Eyedrops by Type (2020-2031)
Figure 57. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Non Corticosteroid Anti-inflammatory Eyedrops by Application (2020-2031)
Figure 59. Global Revenue Market Share of Non Corticosteroid Anti-inflammatory Eyedrops by Application (2020-2031)
Figure 60. Global Non Corticosteroid Anti-inflammatory Eyedrops Price (USD/Unit) by Application (2020-2031)
Figure 61. Non Corticosteroid Anti-inflammatory Eyedrops Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
